Proterra Inc: going-concern / distress — Bankruptcy court confirms Proterra's reorganization plan; common stock canceled, SEC reporting to cease

Proterra Inc

Court confirmed Fifth Amended Joint Chapter 11 Plan on March 6, 2024; existing equity interests canceled with no distribution.
Second Lien Convertible Noteholders to receive ~1,000,000 shares of New Common Stock; other classes paid in cash or reinstated.
Company intends to file Form 15 to deregister common stock and immediately suspend all SEC reporting obligations.
As of March 7, 2024, Proterra had 228,167,279 shares outstanding; all to be canceled upon emergence.
New Common Stock not expected to be listed on any exchange; equity holders receive no recovery.

item 1.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

Proterra Inc entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2023-08-07).

Proceeding: chapter 11
Court: United States Bankruptcy Court for the District of Delaware
Petition: 2023-08-07

Exact text from the filing

As previously reported, on August 7, 2023, Proterra Inc (the "Company"), and its subsidiary Proterra Operating Company, Inc. ("OpCo" and, collectively, the "Debtors") filed voluntary petitions under Chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the United States Bankruptcy Court for the District of Delaware (such court, the "Bankruptcy Court" and such proceedings, the "Chapter 11 Cases"). The Chapter 11 Cases were currently jointly administered under the caption In re Proterra Inc, Case No. 23-11120 (BLS).

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0000950142-24-000649

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.